Search
for
Sort by
Research 541–570 of 1000+
- Harmless Herbs? A Review of the Recent Literature
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Primary cicatricial alopecia
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Effect of Adenovirus-Mediated Expression of Sonic Hedgehog Gene on Hair Regrowth in Mice With Chemotherapy-Induced Alopecia
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Adverse health effects of androgen use
- Male hormonal contraception: looking back and moving forward
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Hair growth promotion by Necrostatin-1s
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- New Treatments for Hair Loss
- Cutaneous Markers of Disorders Affecting Adult Horses
- Clinical use of 5α-reductase inhibitors
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Diuretics
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- New therapies for alopecia areata
- Human Hair as a Testing Substrate in the Era of Precision Medicine: Potential Role of ‘Omics-Based Approaches
- Pharmacological Treatment of Alopecia
- Antihelminthic Drugs
- Isotretinoin
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Follikelhormone
- Efectos de la alteración de los niveles de allopregnanolona durante periodos críticos del neurodesarrollo en la vulnerabilidad al consumo de alcohol
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics